NIH Director's New Innovator Award (DP2 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health is seeking applications for the NIH Director's New Innovator Award to support exceptionally creative early-stage investigators. Awardees will pursue bold, highly innovative research across any scientific field relevant to the NIH mission, with the potential to yield unusually broad and transformative impacts. This funding opportunity, which allows for optional clinical trials, is part of the NIH Common Fund's High-Risk, High-Reward Research Program and targets investigators who have not yet received a substantial NIH independent research award. The agency expects to make approximately 30 awards from an estimated total program budget of $22.7 million, with an individual award ceiling of $475,000. Applications must be submitted by the estimated close date of August 19, 2027, and inquiries can be directed to NewInnovatorAwards@mail.nih.gov.
Eligible Applicants
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Grant Documents
No documents available for this grant.